Due to the development and combination of computer technology, radiation physics, radiation biology, molecular biology and imaging analysis technology, the radiation therapy has made revolutionary progress. The radiation therapy has been developed from 2D to 3D radiotherapy, from the conventional radiotherapy to the precise one. This article summarizes the advances in radiation physics, radiation biology, and clinical radiotherapy and forecasts the future of radiotherapy.
[1] Joosten A, Bochud F, Moeckli R. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2- dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer[J]. Physics in Medicine Biology, 2014, 59(16): 4697-4722.
[2] Schippers M G, Bol G H, de Leeuw A A, et al. Position shifts and volume changes of pelvic and para- aortic nodes during IMRT for patients with cervical cancer[J]. Radiotherapy Oncology, 2014, 111(3): 442-445.
[3] Morimoto M, Yoshioka Y, Konishi K, et al. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity- modulated radiation therapy, three- dimensional conformal radiation therapy, permanent implant brachytherapy and high- dose- rate brachytherapy[J]. Tumori, 2014, 100(3): 265-271.
[4] Hakariya T, Obata S, Iqawa T, et al. Feasibility of simultaneous integrated boost IMRT (SIB- IMRT) for castration- resistant prostate cancer J]. Anticancer Research, 2014, 34(8): 4261-4265.
[5] Vera E, Iorgulescu J B, Raper D M, et al. A review of stereotactic radiosurgery practice in the management of skull base meningiomas[J]. Journal of Neurological Surgery Part B Skull Base, 2014, 75(3): 152- 158.
[6] Katayama S, Hantschke M, Lissner S, et al. Helical tomotherapy of the complete scalp and the ipsilateral lymph nodes in a case of scalp angiosarcoma[J]. Ent-ear Nose & Throat Journal, 2014, 93(6): e24-e28.
[7] 蔡伟明, 李家敏. 质子治疗肿瘤特点及国内外进展[J]. 中华放射肿瘤 学杂志, 2006, 15(4): 349-350. Cai Weiming, Li Jiamin. Progress in proton therapy at home and abroad[J]. Chinese Journal of Radiation Oncology, 2006, 15(4): 349-350.
[8] 丁小凡, 陈龙华. 重离子治疗肿瘤的进展[J]. 中华放射医学与防护杂 志, 2006, 26(5): 536-539. Ding Xiaofan, Chen Longhua. Progress in tumor therapy with heavy ions[J]. Chinese Journal of Radiological Medicine and Protection, 2006, 26(5): 536-539.
[9] 李方明, 聂青, 夏廷毅. 重粒子束高LET射线肿瘤放疗研究进展[J]. 中 国肿瘤, 2008, 17(6): 483-488. Li Fangming, Nie Qing, Xia Tingyi. Research progress in carbon ion beam- high linear energy transfer radiotherapy for cancer[J]. China Cancer, 2008, 17(6):483-488.
[10] Chang E H, Jang Y J, Hao Z, et al. Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild- type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy[J]. Archives of Otolaryngology Head & Neck Surgery, 1997, 123(5): 507- 512.
[11] Pan J J, Zhang S W, Chen C B, et al. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma [J]. Journal of Clinical Oncology, 2009, 27(5): 799-804.
[12] 郎锦义. 现代放射肿瘤学的生物修饰概念与展望[J]. 肿瘤预防与治 疗, 2008, 21(1): 15-17. Lang Jingyi. Biological modification concept and Prospect of modern radiation oncology[J]. Journal of Cancer Control and Treatment, 2008, 21(1): 15-17.
[13] 雷明芳, 杨伟志. 生物影像研究进展及问题[J]. 中华放射肿瘤学杂 志, 2009, 18(6): 501-503. Lei Mingfang, Yang Weizhi. Progress and problems in biological imaging study[J]. Chinese Journal of Radiation Oncology, 2009, 18(6): 501-503.
[14] 于金明, 陈少卿. 生物靶区与生物适形放疗研究进展[J]. 中华肿瘤杂 志, 2006, 28(11): 801-803. Yu Jinming, Chen Shaoqing. Biological target and biological conformal radiotherapy research progress[J]. Chinese Journal of Oncology, 2006, 28(11): 801-803.
[15] Smalley S R, Benedetti J K, Haller D G, et al. Updated analysis of SWOG-directed intergroup study 0116: A phase III trial of adjuvant radio chemotherapy versus observation after curative gastric cancer resection[J]. Journal of Clinical Oncology, 2012, 30(19): 2327-2333.
[16] Wang J, Xia T Y, Wang Y J, et al. Long-term results of gamma raybased stereotacitc body radiation therapy in treatment of medically unfit or inoperable non- metastatic pancreatic adenocarcinoma[J]. International Journal of Radiation Oncology Biology Physics, 2012, 84 (S3): 815-816.
[17] 李光, 于洋洋, 韩冲, 等. 81例胰腺癌后程加量三维适形放疗的疗效 分析[J]. 中国医科大学学报, 2012, 41(12): 1134-1143. Li Guang, Yu Yangyang, Han Chong, et al. Efficacy analysis of threedimensional conformal radiotherapy with increasing dose in late course in 81 cases of pancreatic cancer patients[J]. Journal of China Medical University, 2012, 41(12): 1134-1143.
[18] Ikeda M, Ioka T, Ito Y, et al. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer[J]. International Journal of Radiation Oncology Biology Physics, 2013, 85 (1): 163-169.
[19] Blackstock A W, Tepper J E, Niedwiecki D, et al. Cancer and leukemia group B (CALGB) 89805: Phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas[J]. International Journal of Gastrointestinal Cancer, 2003, 34 (2-3): 107-116.
[20] Timmerman R D, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for medically inoperable early- stage lung cancer patients: Analysis of RTOG 0236[J]. International Journal of Radiation Oncology Biology Physics, 2009, 75(S1): S3.
[21] Zelefsky M J, Levin E J, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity- modulated radiotherapy for localized prostate cancer[J]. International Journal of Radiation Oncology Biology Physics, 2008, 70 (4): 1124-1129.
[22] 唐劲天. 肿瘤质子治疗技术研究进展[J]. 基础医学与临床, 2005, 25 (2): 97-101. Tang Jintian. Progress of proton radiotherapy of cancer[J]. Basic & Clinical Medicine, 2005, 25(2): 97-101.
[23] Wakatsuki M, Kato S, Ohno T, et al. Dose-escalation study of carbon ion radiotherapy for locally advanced aquamous cell carcinoma of the uterine cervix (9902)[J]. Gynecologic Oncology, 2014, 132(1): 87-92.
